New Alzheimer’s drug disappoints in trials
Summary by Ground News
Gantenerumab is part of a class of injected drugs designed to remove sticky protein pieces called beta amyloid from the brain. A buildup of those pieces is a hallmark of Alzheimer's. Roche, the company behind the drug, said it appeared to remove less of the protein pieces than expected.Published 2 months ago
Time & Location
Sources are mostly out of (0)
Bias Distribution
100% of the sources are Center
+2
C 100%
See less detail
